• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Communication Chain of Genetic Risk: Analyses of Narrative Data Exploring Proband-Provider and Proband-Family Communication in Hereditary Breast and Ovarian Cancer.遗传风险的传播链条:对叙述性数据的分析,探索遗传性乳腺癌和卵巢癌中先证者与医疗服务提供者以及先证者与家族之间的沟通情况
J Pers Med. 2022 Jul 29;12(8):1249. doi: 10.3390/jpm12081249.
2
Using a Tailored Digital Health Intervention for Family Communication and Cascade Genetic Testing in Swiss and Korean Families With Hereditary Breast and Ovarian Cancer: Protocol for the DIALOGUE Study.在瑞士和韩国遗传性乳腺癌和卵巢癌家庭中使用定制数字健康干预进行家庭沟通和级联基因检测:DIALOGUE研究方案
JMIR Res Protoc. 2021 Jun 11;10(6):e26264. doi: 10.2196/26264.
3
Exploring family communication preferences in hereditary breast and ovarian cancer and Lynch syndrome: a national Canadian survey.探索遗传性乳腺癌、卵巢癌和林奇综合征患者家庭沟通偏好:一项加拿大全国性调查。
J Community Genet. 2024 Aug;15(4):387-400. doi: 10.1007/s12687-024-00720-z. Epub 2024 Jul 24.
4
Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol.瑞士遗传性乳腺癌/卵巢癌和林奇综合征的癌症易感性级联筛查:研究方案
JMIR Res Protoc. 2017 Sep 20;6(9):e184. doi: 10.2196/resprot.8138.
5
From Probands to Relatives: Communication of Genetic Risk for Hereditary Breast-Ovarian Cancer and Its Influence on Subsequent Testing.从先证者到亲属:遗传性乳腺癌-卵巢癌遗传风险的告知及其对后续检测的影响。
Cancer Nurs. 2022;45(1):E91-E98. doi: 10.1097/NCC.0000000000000876.
6
BRCAShare-Assessment of an animated digital message for intrafamilial communication of pathogenic variant positive test results: A feasibility study.BRCAShare——一项关于用于家族内致病性变异阳性检测结果沟通的动画数字信息的评估:一项可行性研究。
J Genet Couns. 2023 Apr;32(2):475-485. doi: 10.1002/jgc4.1656. Epub 2022 Nov 25.
7
Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study).直接致信有遗传性癌症风险的亲属 - 瑞典癌症遗传诊所开展医疗辅助与家庭介导风险披露的多中心随机对照试验方案(DIRECT 研究)
Trials. 2023 Dec 17;24(1):810. doi: 10.1186/s13063-023-07829-5.
8
A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relatives.从耳语游戏的角度探讨 DNA 检测结果的家庭沟通:BRCA1/2 检测结果在患者与亲属之间沟通过程的回顾性研究。
Fam Cancer. 2011 Mar;10(1):87-96. doi: 10.1007/s10689-010-9385-y.
9
Predicting Openness of Communication in Families With Hereditary Breast and Ovarian Cancer Syndrome: Natural Language Processing Analysis.预测遗传性乳腺癌和卵巢癌综合征家庭中的沟通开放性:自然语言处理分析
JMIR Form Res. 2023 Jan 19;7:e38399. doi: 10.2196/38399.
10
Psychosocial and clinical factors of probands impacting intrafamilial disclosure and uptake of genetic testing among families with BRCA1/2 or MMR gene mutations.BRCA1/2 或 MMR 基因突变家族中先证者的心理社会和临床因素对家族内遗传检测披露和接受的影响。
Psychooncology. 2019 Aug;28(8):1679-1686. doi: 10.1002/pon.5142. Epub 2019 Jun 19.

引用本文的文献

1
Addressing family communication in genetic counseling: A scoping review of process studies.遗传咨询中的家庭沟通问题:过程研究的范围综述
J Genet Couns. 2025 Aug;34(4):e70067. doi: 10.1002/jgc4.70067.
2
Genomic findings with familial implications: agenda setting in light of mainstreaming.具有家族性影响的基因组学发现:基于主流化的议程设定
Open Res Eur. 2025 Jan 10;5:4. doi: 10.12688/openreseurope.19128.1. eCollection 2025.
3
Developing a questionnaire to explore lay people's preferences for communicating hereditary conditions within families: insights from a cognitive interview study.编制一份问卷以探究非专业人士在家庭内部交流遗传疾病方面的偏好:认知访谈研究的见解
J Community Genet. 2025 Mar 18. doi: 10.1007/s12687-025-00783-6.
4
Cascade genetic testing in hereditary cancer: exploring the boundaries of the Italian legal framework.遗传性癌症的级联基因检测:探索意大利法律框架的边界。
Fam Cancer. 2024 Nov 20;24(1):9. doi: 10.1007/s10689-024-00430-y.
5
Clinician perspectives on policy approaches to genetic risk disclosure in families.临床医生对家庭遗传风险披露政策方法的看法。
Fam Cancer. 2024 Jun;23(2):177-186. doi: 10.1007/s10689-024-00375-2. Epub 2024 Mar 28.
6
The experience of receiving a letter from a cancer genetics clinic about risk for hereditary cancer.收到癌症遗传学诊所关于遗传性癌症风险的信件的体验。
Eur J Hum Genet. 2024 May;32(5):539-544. doi: 10.1038/s41431-024-01551-9. Epub 2024 Feb 14.
7
Patients' perceptions and practices of informing relatives: a qualitative study within a randomised trial on healthcare-assisted risk disclosure.患者告知亲属的认知和实践:一项在医疗辅助风险披露随机试验中的定性研究。
Eur J Hum Genet. 2024 Apr;32(4):448-455. doi: 10.1038/s41431-024-01544-8. Epub 2024 Feb 2.
8
Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study).直接致信有遗传性癌症风险的亲属 - 瑞典癌症遗传诊所开展医疗辅助与家庭介导风险披露的多中心随机对照试验方案(DIRECT 研究)
Trials. 2023 Dec 17;24(1):810. doi: 10.1186/s13063-023-07829-5.
9
Cascade testing in Italian Hereditary Breast Ovarian Cancer families: a missed opportunity for cancer prevention?意大利遗传性乳腺癌-卵巢癌家系的级联检测:癌症预防的错失机会?
Fam Cancer. 2024 Jun;23(2):197-207. doi: 10.1007/s10689-023-00349-w. Epub 2023 Nov 16.
10
Acceptability and Usability of the Family Gene Toolkit for Swiss and Korean Families Harboring Pathogenic Variants: A Web-Based Platform for Cascade Genetic Testing.瑞士和韩国携带致病性变异的家庭使用家庭基因工具包的可接受性和可用性:一个用于级联基因检测的基于网络的平台
Cancers (Basel). 2023 Sep 9;15(18):4485. doi: 10.3390/cancers15184485.

本文引用的文献

1
Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort.遗传性乳腺癌和卵巢癌以及林奇综合征相关家庭中告知亲属的意愿、级联检测率和对患者介导沟通的偏好:瑞士级联队列研究
Cancers (Basel). 2022 Mar 23;14(7):1636. doi: 10.3390/cancers14071636.
2
A systematic review of theory-informed strategies used in interventions fostering family genetic risk communication.系统综述:理论指导策略在促进家庭遗传风险沟通干预中的应用
Patient Educ Couns. 2022 Jul;105(7):1953-1962. doi: 10.1016/j.pec.2022.03.009. Epub 2022 Mar 11.
3
Family Adjustment to Hereditary Cancer Syndromes: A Systematic Review.遗传性癌症综合征的家庭适应:系统评价。
Int J Environ Res Public Health. 2022 Jan 30;19(3):1603. doi: 10.3390/ijerph19031603.
4
Genetic Literacy and Communication of Genetic Information in Families Concerned with Hereditary Breast and Ovarian Cancer: A Cross-Study Comparison in Two Countries and within a Timeframe of More Than 10 Years.遗传性乳腺癌和卵巢癌相关家庭中的基因知识素养与基因信息交流:两个国家超过10年时间框架内的跨研究比较
Cancers (Basel). 2021 Dec 13;13(24):6254. doi: 10.3390/cancers13246254.
5
Coping response and family communication of cancer risk in men harboring a BRCA mutation: A mixed methods study.男性携带 BRCA 突变的应对反应和家庭沟通:一项混合方法研究。
Psychooncology. 2022 Mar;31(3):486-495. doi: 10.1002/pon.5831. Epub 2021 Sep 28.
6
Disclosure of genetic information to family members: a systematic review of normative documents.向家庭成员披露遗传信息:规范性文件的系统评价。
Genet Med. 2021 Nov;23(11):2038-2046. doi: 10.1038/s41436-021-01248-0. Epub 2021 Jul 7.
7
Patient and Family Preferences on Health System-Led Direct Contact for Cascade Screening.患者及家属对卫生系统主导的级联筛查直接接触的偏好。
J Pers Med. 2021 Jun 10;11(6):538. doi: 10.3390/jpm11060538.
8
Interventions Facilitating Family Communication of Genetic Testing Results and Cascade Screening in Hereditary Breast/Ovarian Cancer or Lynch Syndrome: A Systematic Review and Meta-Analysis.促进遗传性乳腺癌/卵巢癌或林奇综合征基因检测结果的家庭沟通及级联筛查的干预措施:一项系统评价和荟萃分析
Cancers (Basel). 2021 Feb 23;13(4):925. doi: 10.3390/cancers13040925.
9
What improves the likelihood of people receiving genetic test results communicating to their families about genetic risk?哪些因素提高了人们将基因检测结果告知家人的可能性?
Patient Educ Couns. 2021 Apr;104(4):726-731. doi: 10.1016/j.pec.2021.01.001. Epub 2021 Jan 7.
10
Sharing genetic test results with family members of BRCA, PALB2, CHEK2, and ATM carriers.与 BRCA、PALB2、CHEK2 和 ATM 携带者的家庭成员共享基因检测结果。
Patient Educ Couns. 2021 Apr;104(4):720-725. doi: 10.1016/j.pec.2020.12.019. Epub 2021 Jan 5.

遗传风险的传播链条:对叙述性数据的分析,探索遗传性乳腺癌和卵巢癌中先证者与医疗服务提供者以及先证者与家族之间的沟通情况

The Communication Chain of Genetic Risk: Analyses of Narrative Data Exploring Proband-Provider and Proband-Family Communication in Hereditary Breast and Ovarian Cancer.

作者信息

Pedrazzani Carla, Aceti Monica, Schweighoffer Reka, Kaiser-Grolimund Andrea, Bürki Nicole, Chappuis Pierre O, Graffeo Rossella, Monnerat Christian, Pagani Olivia, Rabaglio Manuela, Katapodi Maria C, Caiata-Zufferey Maria

机构信息

Department of Clinical Research, Faculty of Medicine, University of Basel, 4055 Basel, Switzerland.

Swiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland.

出版信息

J Pers Med. 2022 Jul 29;12(8):1249. doi: 10.3390/jpm12081249.

DOI:10.3390/jpm12081249
PMID:36013197
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9409642/
Abstract

Low uptake of genetic services among members of families with hereditary breast and ovarian cancer (HBOC) suggests limitations of proband-mediated communication of genetic risk. This study explored how genetic information proceeds from healthcare providers to probands and from probands to relatives, from the probands' perspectives. Using a grounded-theory approach, we analyzed narrative data collected with individual interviews and focus groups from a sample of 48 women identified as carriers of HBOC-associated pathogenic variants from three linguistic regions of Switzerland. The findings describe the "communication chain", confirming the difficulties of proband-mediated communication. Provider-proband communication is impacted by a three-level complexity in the way information about family communication is approached by providers, received by probands, and followed-up by the healthcare system. Probands' decisions regarding disclosure of genetic risk are governed by dynamic and often contradictory logics of action, interconnected with individual and family characteristics, eventually compelling probands to engage in an arbitrating process. The findings highlight the relevance of probands' involvement in the communication of genetic risk to relatives, suggesting the need to support them in navigating the complexity of family communication rather than replacing them in this process. Concrete actions at the clinical and health system levels are needed to improve proband-mediated communication.

摘要

遗传性乳腺癌和卵巢癌(HBOC)家族成员对基因检测服务的接受度较低,这表明先证者介导的遗传风险沟通存在局限性。本研究从先证者的角度探讨了遗传信息是如何从医疗服务提供者传递给先证者,以及如何从先证者传递给亲属的。我们采用扎根理论方法,分析了通过个人访谈和焦点小组收集的叙事数据,样本来自瑞士三个语言区域的48名被确定为携带HBOC相关致病变异的女性。研究结果描述了“沟通链”,证实了先证者介导沟通的困难。医疗服务提供者与先证者之间的沟通受到三个层面复杂性的影响,即医疗服务提供者提供关于家族沟通的信息、先证者接收信息以及医疗系统跟进信息的方式。先证者关于披露遗传风险的决定受动态且往往相互矛盾的行动逻辑支配,这些逻辑与个人和家庭特征相互关联,最终迫使先证者参与一个仲裁过程。研究结果凸显了先证者参与向亲属传达遗传风险的重要性,这表明需要支持他们应对家族沟通的复杂性,而不是在这个过程中取代他们。需要在临床和卫生系统层面采取具体行动,以改善先证者介导的沟通。